Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michel L. Belley
Observed names:
M Belley,
M. BELLEY,
M. Belley,
Michel Belley
Institution:
Merck Canada Inc. (Canada)
Observed institutions:
Merck & Co., Inc., Rahway, NJ, USA (United States),
Montreal Heart Institute,
MSD (UK) Limited (United Kingdom),
Merck Canada Inc. (Canada),
Merck Specialities Pvt. Ltd. (India),
Université Laval,
Pharmascience Inc. (Canada),
Université de Montréal
show all 8
OpenAlex ID:
A5002428014
The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs
2000
·
Mark Abramovitz
, Mohammed Adam
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
·
557
Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist
1989
·
T. R. Jones
, R. Zamboni
, et al.
·
Canadian Journal of Physiology and Pharmacology
·
270
Pharmacology of montelukast sodium (Singulair™), a potent and selective leukotriene D4receptor antagonist
1995
·
T. R. Jones
, M. Labelle
, et al.
·
Canadian Journal of Physiology and Pharmacology
·
250
γ-Aminobutyric Acid Type B Receptors with Specific Heterodimer Composition and Postsynaptic Actions in Hippocampal Neurons Are Targets of Anticonvulsant Gabapentin Action
2001
·
Gordon Y.K. Ng
, Sandrine Bertrand
, et al.
·
Molecular Pharmacology
·
146
An efficient synthesis of LTD4 antagonist L-699,392
1993
·
A. O. King
, E. G. Corley
, et al.
·
The Journal of Organic Chemistry
·
137
From indomethacin to a selective COX-2 inhibitor: Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors
1996
·
W.C. Black
, C. Bayly
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
109
Discovery of MK-0476, a potent and orally active leukotriene D4 receptor antagonist devoid of peroxisomal enxyme induction
1995
·
M. Labelle
, M. Belley
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
100
Comparison of the Antinociceptive Profiles of Gabapentin and 3-Methylgabapentin in Rat Models of Acute and Persistent Pain: Implications for Mechanism of Action
2005
·
M.O. Urban
, K. Ren
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
73
The identification of 4,7-disubstituted naphthoic acid derivatives as UDP-competitive antagonists of P2Y14
2011
·
Jacques Yves Gauthier
, Michel Belley
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
61
Discovery of [(3-bromo-7-cyano-2-naphthyl)(difluoro)methyl]phosphonic acid, a potent and orally active small molecule PTP1B inhibitor
2008
·
Yongxin Han
, Michel Belley
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
57
.alpha.-(Arylsulfonamido)borneols as auxiliaries in asymmetric synthesis: an efficient and highly stereoselective method for the reduction of .alpha.-keto esters
1993
·
Yi Bin Xiang
, Ken Snow
, et al.
·
The Journal of Organic Chemistry
·
57
Addition of thiols to styrenes: formation of benzylic thioethers
1989
·
M. Belley
, R. Zamboni
·
The Journal of Organic Chemistry
·
53
Discovery and Synthesis of a Potent, Selective and Orally Bioavailable EP4 Receptor Agonist
2004
·
Robert N. Young
, Xavier Billot
, et al.
·
Heterocycles
·
52
Development of a novel series of styrylquinoline compounds as high-affinity leukotriene D4 receptor antagonists: synthetic and structure-activity studies leading to the discovery of (.+-.)-3-[[[3-[2-(7-chloro-2-quinolinyl)-(E)-ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propionic acid
1992
·
R. Zamboni
, M. Belley
, et al.
·
Journal of Medicinal Chemistry
·
51
Coexpression of full-length gamma-aminobutyric acid(B) (GABA(B)) receptors with truncated receptors and metabotropic glutamate receptor 4 supports the GABA(B) heterodimer as the functional receptor.
2000
·
R Sullivan
, A Chateauneuf
, et al.
·
PubMed
·
49
Differential Effect of a Selective Cyclooxygenase-2 Inhibitor Versus Indomethacin on Renal Blood Flow in Conscious Volume-Depleted Dogs
1998
·
Shawn C. Black
, Christine Brideau
, et al.
·
Journal of Cardiovascular Pharmacology
·
41
Synthesis and SAR of pyrimidine-based, non-nucleotide P2Y14 receptor antagonists
2011
·
Daniel Guay
, Christian Beaulieu
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
39
Synthesis of the Nanomolar Photoaffinity GABAB Receptor Ligand CGP 71872 Reveals Diversity in the Tissue Distribution of GABAB Receptor Forms
1999
·
Michel Belley
, Richard Sullivan
, et al.
·
Bioorganic & Medicinal Chemistry
·
35
Comparison between two classes of selective EP3 antagonists and their biological activities
2006
·
Michel Belley
, Chi Chung Chan
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
32
Synthesis and reactivity of N-hydroxy-2-aminoindoles
2005
·
Michel Belley
, Effiette Sauer
, et al.
·
Tetrahedron Letters
·
32
Intramolecular cyclopropanation of enol ethers: synthetic approach to medium-sized carbocycles
1987
·
Julian Adams
, Richard Frenette
, et al.
·
Journal of the American Chemical Society
·
31
The discovery of a new structural class of potent orally active leukotriene D4 antagonists
1992
·
M. Labelle
, P. Prasit
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
27
A new class of leukotriene biosynthesis inhibitor: the development of MK-0591.
1993
·
P Prasit
, M Belley
, et al.
·
PubMed
·
26
Formation of reactive tricyclic intermediates via the intramolecular cyclopropanation of dihydropyrans. Synthesis of eucalyptol
1986
·
Julian Adams
, Michel Belley
·
Tetrahedron Letters
·
26
Structure–activity relationship studies on ortho-substituted cinnamic acids, a new class of selective EP3 antagonists
2004
·
Michel Belley
, Michel Gallant
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
25
Show more works
View as search
Works count:
69
Citation count:
2,672
H-index:
25
I10-index:
43
Year
Topic
Type